Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

Understanding how much you earn and spend is the key to getting control of your finances. Creating a budget gives you a better sense of where your money is going and can help you achieve financial ...

If you're bored and don't have much spare cash, you don't need to fear a gaming drought. Steam is loaded with games you can play without spending a dime. What's more, many of them are very good indeed ...

If you're just easing into investing, many top brokerages offer free stock-trading platforms that can get you started with zero-commission trading and no account minimums. CNBC Select has chosen the ...